{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:18:27Z","timestamp":1792081107361,"version":"4.4.0"},"reference-count":324,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.critrevonc.2024.104525","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:56:47Z","timestamp":1728089807000},"page":"104525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Associations between peripheral whole blood cell counts derived indexes and cancer prognosis: An umbrella review of meta-analyses of cohort studies"],"prefix":"10.1016","volume":"204","author":[{"given":"Ying-Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Rui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Jie","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Li","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qian","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9421-5114","authenticated-orcid":false,"given":"Qi-Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2024.104525_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12935-019-1032-6","article-title":"Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis","volume":"19","author":"Bao","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104525_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1159\/000502750","article-title":"Platelet-lymphocyte ratio as a predictor of prognosis in head and neck cancer: a systematic review and meta-analysis","volume":"42","author":"Bardash","year":"2019","journal-title":"Oncol. Res. Treat."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2024.104525_bib4","series-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12029-021-00616-y","article-title":"Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in metastatic colorectal cancer","volume":"53","author":"Bulut","year":"2022","journal-title":"J. Gastrointest. Cancer"},{"issue":"14","key":"10.1016\/j.critrevonc.2024.104525_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019638","article-title":"Prognostic significance of lymphocyte monocyte ratio in patients with ovarian cancer","volume":"99","author":"Cai","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2024.104525_bib7","doi-asserted-by":"crossref","unstructured":"Cao, J., Zhu, X., Zhao, X., et al. 2016. Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis. 11(7). Retrieved from <Go to ISI>:\/\/WOS:000378914900052.","DOI":"10.1371\/journal.pone.0158770"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12876-020-1167-x","article-title":"The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis","volume":"20","author":"Cao","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib9","article-title":"Clinical significance of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the prognosis of resected early-stage patients with non-small cell lung cancer: A meta-analysis","author":"Cao","year":"2022","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41419-023-05602-9","article-title":"Levels of systemic inflammation response index are correlated with tumor-associated bacteria in colorectal cancer","volume":"14","author":"Cao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2024.104525_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1180810","article-title":"Neutrophil diversity in inflammation and cancer","volume":"14","author":"Carnevale","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib12","doi-asserted-by":"crossref","unstructured":"Cen, R.-X., & Li, Y.-G. 2019. Platelet-to-lymphocyte ratio as a potential prognostic factor in nasopharyngeal carcinoma A meta-analysis. 98(38). Retrieved from <Go to ISI>:\/\/WOS:000488788000027.","DOI":"10.1097\/MD.0000000000017176"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cllc.2021.01.002","article-title":"Systemic inflammatory markers of survival in epidermal growth factor\u2013mutated non\u2013small-cell lung cancer: single-institution analysis, systematic review, and meta-analysis","volume":"22","author":"Chan","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.critrevonc.2024.104525_bib14","doi-asserted-by":"crossref","unstructured":"Chen, G., Zhu, L., & Yang, Y. 2020. Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis (vol 17, pg 1, 2018). 19. Retrieved from <Go to ISI>:\/\/WOS:000593483500001.","DOI":"10.1177\/1533033818791500"},{"key":"10.1016\/j.critrevonc.2024.104525_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.fob.2015.05.003","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer","volume":"5","author":"Chen","year":"2015","journal-title":"Febs Open Bio"},{"issue":"19","key":"10.1016\/j.critrevonc.2024.104525_bib16","doi-asserted-by":"crossref","first-page":"32356","DOI":"10.18632\/oncotarget.16020","article-title":"Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"34","key":"10.1016\/j.critrevonc.2024.104525_bib17","doi-asserted-by":"crossref","first-page":"57460","DOI":"10.18632\/oncotarget.15404","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2024.104525_bib18","article-title":"Neutrophil-to-lymphocyte ratio is a potential prognostic biomarker in patients with ovarian cancer: a meta-analysis","volume":"2017","author":"Chen","year":"2017","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.critrevonc.2024.104525_bib19","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12935-019-0962-3","article-title":"Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis","volume":"19","author":"Chen","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.critrevonc.2024.104525_bib21","article-title":"Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104525_bib22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/cac2.12345","article-title":"Tumor-associated macrophages in liver cancer: from mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.critrevonc.2024.104525_bib23","doi-asserted-by":"crossref","unstructured":"Cho, J.-K., Kim, M.W., Choi, I.S., et al. 2018. Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study. 18. Retrieved from <Go to ISI>:\/\/WOS:000447148300006.","DOI":"10.1186\/s12885-018-4876-6"},{"issue":"18","key":"10.1016\/j.critrevonc.2024.104525_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015369","article-title":"A meta-analysis of the impact of neutrophil-to-lymphocyte ratio on treatment outcomes after radiotherapy for solid tumors","volume":"98","author":"Choi","year":"2019","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104525_bib25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/MPA.0000000000001878","article-title":"Peripheral blood cell variables related to systemic inflammation in patients with unresectable or metastatic pancreatic cancer: a systematic review and meta-analysis","volume":"50","author":"Colloca","year":"2021","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cam4.4935","article-title":"Prognostic utility of preoperative inflammatory markers in patients with intrahepatic cholangiocarcinoma after hepatic resection: a systematic review and meta-analysis","volume":"12","author":"Cui","year":"2023","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","article-title":"Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies","volume":"18","author":"Cupp","year":"2020","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib28","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.21037\/jtd.2018.02.58","article-title":"Prognostic and clinicopathological significance of platelet to lymphocyte ratio in esophageal cancer: a meta-analysis","volume":"10","author":"Deng","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.critrevonc.2024.104525_bib29","unstructured":"Dhani,\u00a0F.K.,\u00a0Budaya,\u00a0T.N.U.R.,\u00a0Yahya,\u00a0H.,\u00a0et al.,\u00a02020.\u00a0Predict. significance neutrophil-to-Lymph. Ratio (NLR) Bladder Carcinoma Patient-.: a Syst. Rev. meta-Anal.\u00a014\u00a0(4),\u00a01610\u20131615\u00a0Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2010845778&from=export\u3009."},{"key":"10.1016\/j.critrevonc.2024.104525_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep34823","article-title":"The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort","volume":"6","author":"Ding","year":"2016","journal-title":"Sci. Rep."},{"issue":"30","key":"10.1016\/j.critrevonc.2024.104525_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011446","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in melanoma: evidence from a PRISMA-compliant meta-analysis","volume":"97","author":"Ding","year":"2018","journal-title":"Medicine"},{"issue":"10258","key":"10.1016\/j.critrevonc.2024.104525_bib32","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Diseases","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16955-5","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis","volume":"7","author":"Dolan","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16955-5","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis","volume":"7","author":"Dolan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2024.104525_bib35","doi-asserted-by":"crossref","unstructured":"Dong, Y.-w, Shi, Y.-q, He, L.-w, et al. 2016. Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis. 9, 3127-3134. Retrieved from <Go to ISI>:\/\/WOS:000376648600001.","DOI":"10.2147\/OTT.S103031"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104525_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12112655","article-title":"Lymphocyte-to-monocyte ratio and clinical outcomes in cholangiocarcinoma: a systematic review and meta-analysis","volume":"12","author":"Dotto-Vasquez","year":"2022","journal-title":"Diagnostics"},{"issue":"13","key":"10.1016\/j.critrevonc.2024.104525_bib37","doi-asserted-by":"crossref","first-page":"17638","DOI":"10.18632\/aging.203256","article-title":"Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy","volume":"13","author":"Du","year":"2021","journal-title":"Aging"},{"issue":"49","key":"10.1016\/j.critrevonc.2024.104525_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013340","article-title":"Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer: a meta-analysis","volume":"97","author":"Duan","year":"2018","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13058-016-0794-1","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis","volume":"19","author":"Ethier","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ygyno.2017.02.026","article-title":"Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? a systematic review and meta-analysis","volume":"145","author":"Ethier","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"20","key":"10.1016\/j.critrevonc.2024.104525_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019686","article-title":"Clinical and prognostic value of neutrophil-lymphocyte ratio for patients with thyroid cancer: a meta-analysis","volume":"99","author":"Feng","year":"2020","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104525_bib42","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.7150\/jca.50552","article-title":"Prognostic value of peripheral blood lymphocyte\/monocyte ratio in lymphoma","volume":"12","author":"Gao","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104525_bib43","unstructured":"Gao, N., Yang, A.Q., Ma, R., et al. 2019. Pretreatment platelet to lymphocyte ratio is associated with breast cancer prognosis: an updated meta-analysis. 12(10), 12028-12037. Retrieved from <Go to ISI>:\/\/WOS:000493908100005."},{"key":"10.1016\/j.critrevonc.2024.104525_bib44","doi-asserted-by":"crossref","unstructured":"Gao, P., Peng, W., & Hu, Y. 2022. Prognostic and clinicopathological significance of lymphocyte-to-monocyte ratio in patients with nasopharyngeal carcinoma: A meta-analysis. 44(3), 624-632. Retrieved from <Go to ISI>:\/\/WOS:000745821800001.","DOI":"10.1002\/hed.26952"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104525_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.10350","article-title":"Association of neutrophil to lymphocyte ratio with pulmonary function in a 30-year longitudinal study of US veterans","volume":"3","author":"Gao","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.critrevonc.2024.104525_bib46","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2147\/CMAR.S184970","article-title":"Pretreatment lymphocyte-to-monocyte ratio as a predictor of survival among patients with ovarian cancer: a meta-analysis","volume":"11","author":"Gao","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.critrevonc.2024.104525_bib47","doi-asserted-by":"crossref","unstructured":"Garcia-Rojo, D., Prera, A., Munoz-Rodriguez, J., et al. 2021. Prognostic value of lymphocyte-to-monocyte ratio previously determined to surgery in patients with non-metastatic renal cell carcinoma A systematic review and a prisma-compliant meta-analysis. 100(3). Retrieved from <Go to ISI>:\/\/WOS:000612835100109.","DOI":"10.1097\/MD.0000000000024152"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12967-023-04418-7","article-title":"Eosinophils in the tumor microenvironment: implications for cancer immunotherapy","volume":"21","author":"Ghaffari","year":"2023","journal-title":"J. Transl. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/03936155221118098","article-title":"Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: a meta-analysis","volume":"37","author":"Gong","year":"2022","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.critrevonc.2024.104525_bib50","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients","volume":"6","author":"Gu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2024.104525_bib51","unstructured":"Gu,\u00a0X.,\u00a0Gao,\u00a0X.S.,\u00a0Qin,\u00a0S.,\u00a0et al.,\u00a02016.\u00a0Progn. Value neutrophil Lymph. Ratio Patients Bladder Cancer.: A meta-Anal.\u00a09\u00a0(11)),\u00a020615\u201320623\u00a0Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L613465638&from=export\u3009."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163523","article-title":"Elevated platelet to lymphocyte ratio is associated with poor survival outcomes in patients with colorectal cancer","volume":"11","author":"Gu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2024.104525_bib53","doi-asserted-by":"crossref","unstructured":"Gu, X., Sun, S., Gao, X.-S., et al. 2016. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients. 6. Retrieved from <Go to ISI>:\/\/WOS:000373050800001.","DOI":"10.1038\/srep23893"},{"key":"10.1016\/j.critrevonc.2024.104525_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/srep12493","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis","volume":"5","author":"Gu","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104525_bib55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41391-020-0209-3","article-title":"Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis","volume":"23","author":"Guan","year":"2020","journal-title":"Prostate Cancer prostatic Dis."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104525_bib56","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","article-title":"A neutrophil response linked to tumor control in immunotherapy","volume":"186","author":"Gungabeesoon","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2024.104525_bib57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijsu.2018.11.020","article-title":"Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis","volume":"60","author":"Guo","year":"2018","journal-title":"Int. J. Surg. (Lond., Engl. )"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib58","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1002\/cam4.2281","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: an updated meta-analysis of 17079 individuals","volume":"8","author":"Guo","year":"2019","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12050675","article-title":"Pre-treatment and preoperative neutrophil-to-lymphocyte ratio predicts prognostic value of glioblastoma: a meta-analysis","volume":"12","author":"Guo","year":"2022","journal-title":"Brain Sci."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104525_bib60","doi-asserted-by":"crossref","first-page":"20011","DOI":"10.18632\/oncotarget.15311","article-title":"The clinical use of the platelet\/lymphocyte ratio and lymphocyte\/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2024.104525_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2021.101556","article-title":"Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis","volume":"37","author":"Hamid","year":"2021","journal-title":"Surg. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104525_bib62","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/DCR.0000000000002291","article-title":"Prognostic significance of lymphocyte-to-monocyte and platelet-to-lymphocyte ratio in rectal cancer: a systematic review, meta-analysis, and meta-regression","volume":"65","author":"Hamid","year":"2022","journal-title":"Dis. Colon Rectum"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/kjm2.12290","article-title":"Prognostic and clinicopathological significance of the platelet-to-lymphocyte ratio in melanoma: a meta-analysis involving 2099 patients","volume":"37","author":"Han","year":"2021","journal-title":"Kaohsiung J. Med Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2020.10.011","article-title":"Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: a systemic review, meta-analysis, and meta-regression of observational studies","volume":"160","author":"Han","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"7414","key":"10.1016\/j.critrevonc.2024.104525_bib65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104525_bib66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14715\/cmb\/2017.63.8.7","article-title":"Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): a meta-analysis","volume":"63","author":"Hu","year":"2017","journal-title":"Cell Mol. Biol. (Noisy-Le. -Gd. )"},{"key":"10.1016\/j.critrevonc.2024.104525_bib67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cca.2018.07.029","article-title":"Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis","volume":"486","author":"Hu","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.critrevonc.2024.104525_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7375169","article-title":"Prognostic significance of platelet-to-lymphocyte ratio in cholangiocarcinoma: a meta-analysis","volume":"2018","author":"Hu","year":"2018","journal-title":"BioMed. Res. Int."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265897","article-title":"Elevated baseline circulating platelet-to-lymphocyte ratio and survival in initial stage \u2163 gastric cancer patients: a meta-analysis","volume":"17","author":"Hu","year":"2022","journal-title":"PLoS One"},{"issue":"4 April","key":"10.1016\/j.critrevonc.2024.104525_bib70","article-title":"Elevated baseline circulating platelet-tolymphocyte ratio and survival in initial stage IV gastric cancer patients: a meta-analysis","volume":"17","author":"Hu","year":"2022","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib71","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00345-018-2593-z","article-title":"The prognostic role of preoperative circulating neutrophil-lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy: a meta-analysis","volume":"37","author":"Hu","year":"2019","journal-title":"World J. Urol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib72","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00345-018-2593-z","article-title":"The prognostic role of preoperative circulating neutrophil-lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy: a meta-analysis","volume":"37","author":"Hu","year":"2019","journal-title":"World J. Urol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006404","article-title":"Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis","volume":"5","author":"Hu","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.critrevonc.2024.104525_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2018.05.031","article-title":"Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: a meta-analysis","volume":"484","author":"Hu","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.critrevonc.2024.104525_bib75","article-title":"Prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in laryngeal cancer: what should we expect from a meta-analysis?","volume":"12","author":"Hu","year":"2022","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104525_bib76","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hed.27246","article-title":"Neutrophil-to-lymphocyte and hypopharyngeal cancer prognosis: system review and meta-analysis","volume":"45","author":"Hu","year":"2023","journal-title":"Head. Neck"},{"issue":"18","key":"10.1016\/j.critrevonc.2024.104525_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184589","article-title":"Pretreatment neutrophil-to-lymphocyte ratio associated with tumor recurrence and survival in patients achieving a pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104525_bib78","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1159\/000475911","article-title":"Prognostic significance of neutrophil-tolymphocyte ratio in ovarian cancer: a systematic review and meta-analysis of observational studies","volume":"41","author":"Huang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.critrevonc.2024.104525_bib79","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1053125","article-title":"An elevated platelet-to-lymphocyte ratio predicts poor prognosis and clinicopathological characteristics in patients with colorectal cancer: a meta-analysis","volume":"2017","author":"Huang","year":"2017","journal-title":"Dis. Markers"},{"key":"10.1016\/j.critrevonc.2024.104525_bib80","article-title":"Dietary sugar consumption and health: umbrella review","volume":"381","author":"Huang","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2024.104525_bib81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2147\/OTT.S126637","article-title":"Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysis","volume":"10","author":"Huang","year":"2017","journal-title":"Onco Targets Ther."},{"issue":"7626","key":"10.1016\/j.critrevonc.2024.104525_bib82","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"Ioannidis","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2024.104525_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103427","article-title":"Prognostic value of platelet-related measures for overall survival in esophageal squamous cell carcinoma: a systematic review and meta-analysis","volume":"164","author":"Ishibashi","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ags3.12294","article-title":"Prognostic significance of systemic inflammatory markers in esophageal cancer: systematic review and meta-analysis","volume":"4","author":"Ishibashi","year":"2020","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.critrevonc.2024.104525_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8839512","article-title":"Prognostic value of pretreated blood inflammatory markers in patients with bone sarcoma: a meta-analysis","volume":"2021","author":"Jiang","year":"2021","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib86","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00404-019-05257-y","article-title":"Platelet\u2013lymphocyte ratio as a potential prognostic factor in gynecologic cancers: a meta-analysis","volume":"300","author":"Jiang","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib87","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00262-018-2126-z","article-title":"Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis","volume":"67","author":"Jiang","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib88","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048324","article-title":"Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis","volume":"11","author":"Jiang","year":"2021","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104525_bib89","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035031","article-title":"Association of the neutrophil to lymphocyte ratio and clinical outcomes in patients with lung cancer receiving immunotherapy: a meta-analysis","volume":"10","author":"Jin","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.critrevonc.2024.104525_bib90","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820983085","article-title":"Prognostic value of pretreatment lymphocyte-to-monocyte ratio in lung cancer: a systematic review and meta-analysis","volume":"20","author":"Jin","year":"2021","journal-title":"Technol. Cancer Res Treat."},{"key":"10.1016\/j.critrevonc.2024.104525_bib91","doi-asserted-by":"crossref","first-page":"j4511","DOI":"10.1136\/bmj.j4511","article-title":"Obesity and gynaecological and obstetric conditions: umbrella review of the literature","volume":"359","author":"Kalliala","year":"2017","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104525_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236445","article-title":"Inflammatory markers for predicting overall survival in gastric cancer patients: a systematic review and meta-analysis","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"issue":"7967","key":"10.1016\/j.critrevonc.2024.104525_bib93","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4(+) T cell-induced inflammatory cell death controls immune-evasive tumours.","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.critrevonc.2024.104525_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164166","article-title":"Prognostic utility of platelet-lymphocyte ratio, neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in head and neck cancers: a detailed PRISMA compliant systematic review and meta-analysis","volume":"13","author":"Kumarasamy","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104525_bib95","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1148\/radiol.2282011860","article-title":"Measurement of observer agreement","volume":"228","author":"Kundel","year":"2003","journal-title":"Radiology"},{"issue":"15","key":"10.1016\/j.critrevonc.2024.104525_bib96","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3748\/wjg.v24.i15.1658","article-title":"Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: a systematic review and meta-analysis","volume":"24","author":"Lai","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib97","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"Lau","year":"1997","journal-title":"Ann. Intern Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib98","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12885-019-5552-1","article-title":"Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis","volume":"19","author":"Lee","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2024.104525_bib99","article-title":"Meta-analysis on the neutrophil-lymphocyte ratio in rectal cancer treated with preoperative chemoradiotherapy: prognostic value of pre- and post-chemoradiotherapy neutrophil-lymphocyte ratio","volume":"12","author":"Lee","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12957-019-1686-5","article-title":"Prognostic impact of neutrophil-to-lymphocyte ratio in gliomas: a systematic review and meta-analysis","volume":"17","author":"Lei","year":"2019","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.734948","article-title":"Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio, platelet\u2212to\u2212lymphocyte ratio, or monocyte-to-lymphocyte ratio in endometrial neoplasms: a systematic review and meta\u2212analysis","volume":"12","author":"Leng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib102","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211070140","article-title":"Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal cancer: an update meta-analysis","volume":"21","author":"Li","year":"2022","journal-title":"Technol. Cancer Res Treat."},{"key":"10.1016\/j.critrevonc.2024.104525_bib103","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2018.04.023","article-title":"Platelet-to-lymphocyte ratio in advanced Cancer: ceview and meta-analysis","volume":"483","author":"Li","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib104","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001341","article-title":"Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer","volume":"9","author":"Li","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104525_bib105","article-title":"The Prognostic value of platelet-to-lymphocyte ratio in urological cancers: a meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2024.104525_bib106","doi-asserted-by":"crossref","DOI":"10.21037\/tcr-22-1197","article-title":"Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis","author":"Li","year":"2022","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib107","article-title":"Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: a meta-analysis","volume":"98","author":"Li","year":"2019","journal-title":"Med. (Baltim. )"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104525_bib108","article-title":"Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: a PRISMA-compliant meta-analysis","volume":"98","author":"Li","year":"2019","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.critrevonc.2024.104525_bib109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fonc.2020.00030","article-title":"Meta-analysis of hematological biomarkers as reliable indicators of soft tissue sarcoma prognosis","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.prp.2018.10.026","article-title":"The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: a meta-analysis","volume":"215","author":"Li","year":"2019","journal-title":"Pathol. Res Pr."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104525_bib111","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/ijc.28536","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis","volume":"134","author":"Li","year":"2014","journal-title":"Int J. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104525_bib112","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4251\/wjgo.v12.i10.1146","article-title":"Comparison of prognostic factors in different age groups and prognostic significance of neutrophil-lymphocyte ratio in patients with gastric cancer","volume":"12","author":"Li","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230879","article-title":"Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: a systematic review and meta-analysis","volume":"15","author":"Li","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib114","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","article-title":"The dynamic role of platelets in cancer progression and their therapeutic implications","volume":"24","author":"Li","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"66","key":"10.1016\/j.critrevonc.2024.104525_bib115","doi-asserted-by":"crossref","first-page":"110606","DOI":"10.18632\/oncotarget.20574","article-title":"Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104525_bib116","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009616","article-title":"Prognostic role of platelet to lymphocyte ratio in pancreatic cancers","volume":"97","author":"Li","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2024.104525_bib117","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2147\/OTT.S142022","article-title":"Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2017","journal-title":"Onco Targets Ther."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib118","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7150\/jca.23367","article-title":"The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2018","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib119","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12935-023-02876-z","article-title":"The prognostic utility of preoperative neutrophil-to-lymphocyte ratio (NLR) in patients with colorectal liver metastasis: a systematic review and meta-analysis","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.critrevonc.2024.104525_bib120","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fonc.2020.00654","article-title":"Pretreatment neutrophil-to-lymphocyte ratio (NLR) May Predict the outcomes of advanced non-small-cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs)","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104525_bib121","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1039\/D1FO03094A","article-title":"Cruciferous vegetable consumption and multiple health outcomes: an umbrella review of 41 systematic reviews and meta-analyses of 303 observational studies","volume":"13","author":"Li","year":"2022","journal-title":"Food Funct."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib122","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3109\/10428194.2015.1014367","article-title":"Prognostic role of peripheral blood lymphocyte\/monocyte ratio at diagnosis in diffuse large B-cell lymphoma: a meta-analysis","volume":"56","author":"Lin","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2024.104525_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106959","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer liver metastasis: a meta-analysis of results from multivariate analysis","volume":"107","author":"Lin","year":"2022","journal-title":"Int J. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib124","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12957-020-01962-0","article-title":"Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients","volume":"18","author":"Lin","year":"2020","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib125","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024153","article-title":"Clinicopathological and prognostic value of preoperative lymphocyte to monocyte ratio for hepatocellular carcinoma following curative resection: a meta-analysis including 4,092 patients","volume":"100","author":"Lin","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2024.104525_bib126","article-title":"Prognostic role of platelet-to-lymphocyte ratio in hepatocellular carcinoma with different BCLC stages: a systematic review and meta-analysis","volume":"2018","author":"Lin","year":"2018","journal-title":"Gastroenterol. Res Pr."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104525_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020438","article-title":"The value of platelet-to-lymphocyte ratio as a prognostic marker in cholangiocarcinoma: a systematic review and meta-analysis","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib128","article-title":"The prognostic value of neutrophil-to-lymphocyte ratio in cholangiocarcinoma: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"issue":"36","key":"10.1016\/j.critrevonc.2024.104525_bib129","article-title":"Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: a meta-analysis","volume":"97","author":"Liu","year":"2018","journal-title":"Med. (Baltim. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib130","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s12935-021-02391-z","article-title":"Prognostic significance of the neutrophil-to-lymphocyte ratio in peripheral T-cell lymphoma: a meta-analysis","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.critrevonc.2024.104525_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01557","article-title":"Prognostic roles of blood inflammatory markers in hepatocellular carcinoma patients taking sorafenib. a systematic review and meta-analysis","volume":"9","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib132","unstructured":"Liu, Q., Ma, J., & Zhou, L. 2018. The preoperative platelet-to-lymphocyte ratio predicts clinical outcomes in patients with gastrointestinal stromal tumors: a meta-analysis. International Journal of Clinical and Experimental Medicine, 11(4), 3051-3059. Retrieved from <Go to ISI>:\/\/WOS:000431333500013."},{"issue":"45","key":"10.1016\/j.critrevonc.2024.104525_bib133","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008101","article-title":"Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: a meta-analysis","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2024.104525_bib134","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fonc.2020.00178","article-title":"Preoperative neutrophil lymphocyte ratio can be used as a predictor of prognosis in patients with adenocarcinoma of the esophagogastric junction: a systematic review and meta analysis","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104525_bib135","first-page":"11090","article-title":"Platelet to lymphocyte ratio might be a prognostic factor of colorectal cancer (CRC): a meta-analysis","volume":"9","author":"Liu","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"28","key":"10.1016\/j.critrevonc.2024.104525_bib136","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio for patients with triple-negative breast cancer: a meta-analysis","volume":"101","author":"Liu","year":"2022","journal-title":"Med. (Baltim. )"},{"issue":"29","key":"10.1016\/j.critrevonc.2024.104525_bib137","article-title":"Prognostic value of platelet-to-lymphocyte ratio in neoadjuvant chemotherapy for solid tumors: a PRISMA-compliant meta-analysis","volume":"100","author":"Long","year":"2021","journal-title":"Med. (Baltim. )"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104525_bib138","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004440","article-title":"Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer","volume":"10","author":"Lopez de Rodas","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"24","key":"10.1016\/j.critrevonc.2024.104525_bib139","article-title":"Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis","volume":"98","author":"Lu","year":"2019","journal-title":"Med. (Baltim. )"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230979","article-title":"The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: a meta-analysis","volume":"15","author":"Lu","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib141","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euf.2015.03.001","article-title":"The neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy: validation and meta-analysis","volume":"2","author":"Lucca","year":"2016","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.critrevonc.2024.104525_bib142","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2017.11.029","article-title":"Prognostic significance of neutrophil to lymphocyte ratio in patients with gastrointestinal stromal tumors: A meta-analysis","volume":"477","author":"Luo","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib143","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820977135","article-title":"Chemotherapy-induced reduction of neutrophil-to-lymphocyte ratio is associated with better survival in pancreatic adenocarcinoma: a meta-analysis","volume":"27","author":"Luo","year":"2020","journal-title":"Cancer Control"},{"issue":"40","key":"10.1016\/j.critrevonc.2024.104525_bib144","article-title":"Pretreatment neutrophil to lymphocyte ratio as a prognostic predictor of urologic tumors: a systematic review and meta-analysis","volume":"94","author":"Luo","year":"2015","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.critrevonc.2024.104525_bib145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijsu.2018.01.002","article-title":"Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: a meta-analysis","volume":"50","author":"Ma","year":"2018","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.critrevonc.2024.104525_bib146","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7593560","article-title":"Prognostic significance of the lymphocyte-to-monocyte ratio in bladder cancer undergoing radical cystectomy: a meta-analysis of 5638 individuals","volume":"2019","author":"Ma","year":"2019","journal-title":"Dis. Markers"},{"issue":"43","key":"10.1016\/j.critrevonc.2024.104525_bib147","article-title":"The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: a meta-analysis","volume":"97","author":"Ma","year":"2018","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.critrevonc.2024.104525_bib148","article-title":"Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib149","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/13697137.2017.1326894","article-title":"The platelet-to-lymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a meta-analysis","volume":"20","author":"Ma","year":"2017","journal-title":"Climacteric"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104525_bib150","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1245\/s10434-014-3815-2","article-title":"The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis","volume":"21","author":"Malietzis","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib151","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12935-018-0698-5","article-title":"Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis","volume":"18","author":"Mao","year":"2018","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib152","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clgc.2016.12.027","article-title":"High neutrophil-to-lymphocyte ratio as prognostic factor in patients affected by upper tract urothelial cancer: a systematic review and meta-analysis","volume":"15","author":"Marchioni","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib153","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jop.13264","article-title":"Pre-treatment neutrophil-to-lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: meta-analysis and trial sequential analysis","volume":"51","author":"Mariani","year":"2022","journal-title":"J. Oral. Pathol. Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib154","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/hed.25075","article-title":"Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: a systematic review and meta-analysis","volume":"40","author":"Mascarella","year":"2018","journal-title":"Head. Neck"},{"key":"10.1016\/j.critrevonc.2024.104525_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1321584","article-title":"Prognostic value of lymphocyte-to-monocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"14","author":"Mei","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2017.05.005","article-title":"Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: a systematic review and meta-analysis of 66 cohort studies","volume":"58","author":"Mei","year":"2017","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib157","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13151","article-title":"The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: a systematic review and meta-analysis","volume":"32","author":"Min","year":"2018","journal-title":"Clin. Transpl."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib158","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2217\/bmm-2016-0181","article-title":"The prognostic role of pretreatment platelet-to-lymphocyte ratio as predictors in patients with colorectal cancer: a meta-analysis","volume":"11","author":"Min","year":"2017","journal-title":"Biomark. Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib159","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.urolonc.2020.01.015","article-title":"Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: a systematic review and meta-analysis","volume":"38","author":"Mori","year":"2020","journal-title":"Urol. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104525_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/biom13121803","article-title":"NeutrOphil-to-lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, And Other Solid Tumors: Immunotherapy And Beyond","volume":"13","author":"Mosca","year":"2023","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib161","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.hpb.2017.12.009","article-title":"A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection","volume":"20","author":"Mowbray","year":"2018","journal-title":"HPB (Oxf. )"},{"key":"10.1016\/j.critrevonc.2024.104525_bib162","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2147\/OTT.S153146","article-title":"Prognostic role of neutrophil\u2013lymphocyte ratio in multiple myeloma: a dose\u2013response meta-analysis","volume":"11","author":"Mu","year":"2018","journal-title":"OncoTargets Ther."},{"issue":"28","key":"10.1016\/j.critrevonc.2024.104525_bib163","doi-asserted-by":"crossref","first-page":"44039","DOI":"10.18632\/oncotarget.9836","article-title":"Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors","volume":"7","author":"Na","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib164","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00404-019-05372-w","article-title":"Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis","volume":"301","author":"Ni","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104525_bib165","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ctrv.2015.10.003","article-title":"Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis","volume":"41","author":"Nishijima","year":"2015","journal-title":"Cancer Treat. Rev."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104525_bib166","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","article-title":"Systemic inflammation markers and cancer incidence in the UK Biobank","volume":"36","author":"Nost","year":"2021","journal-title":"Eur. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104525_bib167","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/imt-2018-0175","article-title":"Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis","volume":"11","author":"Nunno","year":"2019","journal-title":"Immunotherapy"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12030737","article-title":"The predicting role of the neutrophil-to-lymphocyte ratio for the tumor grade and prognosis in pancreatic neuroendocrine tumors","volume":"12","author":"Oh","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.critrevonc.2024.104525_bib169","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib170","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib171","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.suronc.2013.12.001","article-title":"A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours","volume":"23","author":"Paramanathan","year":"2014","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib172","unstructured":"Peng, B., Wang, Y.-H., Liu, Y.-M., et al. 2015. Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis. 8(3), 3098-3106. Retrieved from <Go to ISI>:\/\/WOS:000355307300003."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104525_bib173","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/2211-5463.12083","article-title":"Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysis","volume":"6","author":"Peng","year":"2016","journal-title":"Febs Open Bio"},{"key":"10.1016\/j.critrevonc.2024.104525_bib174","doi-asserted-by":"crossref","unstructured":"Peng, L.-P., Li, J., & Li, X.-F. 2022. Prognostic value of neutrophil\/lymphocyte, platelet\/lymphocyte, lymphocyte\/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis. 10(7), 2194-2205. Retrieved from <Go to ISI>:\/\/WOS:000797355700015.","DOI":"10.12998\/wjcc.v10.i7.2194"},{"key":"10.1016\/j.critrevonc.2024.104525_bib175","article-title":"Utility of pretreatment blood platelet-to-lymphocyte ratio in prediction of clinical outcomes and chemosensitivity in patients with advanced gastric cancer: a meta-analysis","volume":"28","author":"Peng","year":"2022","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.critrevonc.2024.104525_bib176","doi-asserted-by":"crossref","unstructured":"Pirozzolo, G., Gisbertz, S.S., Castoro, C., et al. 2019. Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis. 11(7), 3136-3145. Retrieved from <Go to ISI>:\/\/WOS:000477975100063.","DOI":"10.21037\/jtd.2019.07.30"},{"key":"10.1016\/j.critrevonc.2024.104525_bib177","doi-asserted-by":"crossref","unstructured":"Pirozzolo,\u00a0G.,\u00a0Gisbertz,\u00a0S.S.,\u00a0Castoro,\u00a0C.,\u00a0et al.,\u00a02017.\u00a0Neutrophil Lymph. Ratio Predict. Marker Surviv. esophageal Cancer.: Syst. Rev. meta-Anal.\u00a05\u00a0(5),\u00a0A84\u00a0Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L619892226&from=exporthttp:\/\/dx.doi.org\/10.1177\/2050640617725668\u3009.","DOI":"10.1177\/2050640617725668"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104525_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/medicina58081069","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers for advanced non-small-cell lung cancer treated with immunotherapy: a systematic review and meta-analysis","volume":"58","author":"Platini","year":"2022","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib179","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00423-023-02786-8","article-title":"Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis","volume":"408","author":"Portale","year":"2023","journal-title":"Lange 'S. Arch. Surg."},{"issue":"29","key":"10.1016\/j.critrevonc.2024.104525_bib180","doi-asserted-by":"crossref","first-page":"45283","DOI":"10.18632\/oncotarget.9942","article-title":"Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies","volume":"7","author":"Qi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2024.104525_bib181","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2147\/OTT.S96804","article-title":"Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis","volume":"9","author":"Qiang","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.critrevonc.2024.104525_bib182","doi-asserted-by":"crossref","unstructured":"Riauka, R., Ignatavicius, P., Gribauskaite, J., et al. 2020. Preoperative platelet to lymphocyte ratio as a prognostic factor for resectable pancreatic cancer: A systematic review and meta-analysis. 22, S204. Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2008010575&from=exporthttp:\/\/dx.doi.org\/10.1016\/j.hpb.2020.04.025\u3009.","DOI":"10.1016\/j.hpb.2020.04.025"},{"key":"10.1016\/j.critrevonc.2024.104525_bib183","doi-asserted-by":"crossref","unstructured":"Rodrigo, J.P., S\u00e1nchez-Canteli, M., Triantafyllou, A., et al. 2023. Neutrophil to Lymphocyte Ratio in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis \u2020. 15(3). Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2021411359&from=exporthttp:\/\/dx.doi.org\/10.3390\/cancers15030802\u3009.","DOI":"10.3390\/cancers15030802"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104525_bib184","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s11154-023-09845-x","article-title":"Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis","volume":"24","author":"Russo","year":"2023","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.critrevonc.2024.104525_bib185","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in penile cancer: A systematic review and meta-analysis","volume":"81","author":"Saputra","year":"2022","journal-title":"Ann. Med. Surg. (2012)"},{"key":"10.1016\/j.critrevonc.2024.104525_bib186","doi-asserted-by":"crossref","unstructured":"Savioli, F., Morrow, E., Dolan, R., et al. 2021. P167. The prognostic role of preoperative circulating markers of the systemic inflammatory response in primary operable breast cancer: A systematic review and meta-analysis. 47(5), e340-e341. Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2011925900&from=exporthttp:\/\/dx.doi.org\/10.1016\/j.ejso.2021.03.171\u3009.","DOI":"10.1016\/j.ejso.2021.03.171"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104525_bib187","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/bjs\/znac319","article-title":"Prognostic role of preoperative circulating systemic inflammatory response markers in primary breast cancer: meta-analysis","volume":"109","author":"Savioli","year":"2022","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104525_bib188","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3945\/an.116.013052","article-title":"Perspective: NutriGrade: a scoring system to assess and judge the meta-evidence of randomized controlled trials and cohort studies in nutrition research","volume":"7","author":"Schwingshackl","year":"2016","journal-title":"Adv. Nutr."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib189","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/j.clgc.2018.01.010","article-title":"Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and c-reactive protein as new and simple prognostic factors in patients with metastatic renal cell cancer treated with tyrosine kinase inhibitors: a systemic review and meta-analysis","volume":"16","author":"Semeniuk-Wojta\u015b","year":"2018","journal-title":"Clin. Genitourin. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12957-020-02048-7","article-title":"Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis","volume":"18","author":"Shao","year":"2020","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib191","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12894-020-00665-8","article-title":"Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis","volume":"20","author":"Shao","year":"2020","journal-title":"BMC Urol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib192","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Method."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104525_bib193","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jclinepi.2008.10.009","article-title":"AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews","volume":"62","author":"Shea","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib194","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1177403","article-title":"The preoperative platelet to neutrophil ratio and lymphocyte to monocyte ratio are superior prognostic indicators compared with other inflammatory biomarkers in ovarian cancer","volume":"14","author":"Song","year":"2023","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104525_bib195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178762","article-title":"Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: a systematic review and meta-analysis","volume":"12","author":"Song","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2024.104525_bib196","article-title":"The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: a meta-analysis","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"issue":"49","key":"10.1016\/j.critrevonc.2024.104525_bib197","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005540","article-title":"Prognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: a meta-analysis","volume":"95","author":"Song","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2024.104525_bib198","doi-asserted-by":"crossref","unstructured":"Song, W., Wang, K., Zhong, F.-P., et al. 2016. Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma. 7(49), 81830-81838. Retrieved from <Go to ISI>:\/\/WOS:000389877500138.","DOI":"10.18632\/oncotarget.13244"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib199","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4(+) T cells in cancer.","volume":"4","author":"Speiser","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104525_bib200","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-Reactive Protein at Sites of Inflammation and Infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib201","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.critrevonc.2024.104525_bib202","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104525_bib203","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006364","article-title":"Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis","volume":"96","author":"Su","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2024.104525_bib204","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijsu.2019.10.043","article-title":"Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: a systematic review and meta-analysis","volume":"72","author":"Su","year":"2019","journal-title":"Int. J. Surg. (Lond., Engl. )"},{"key":"10.1016\/j.critrevonc.2024.104525_bib205","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fonc.2019.01365","article-title":"Clinical significance of pre-treated neutrophil-lymphocyte ratio in the management of urothelial carcinoma: a systemic review and meta-analysis","volume":"9","author":"Suh","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib206","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7862469","article-title":"Can the neutrophil to lymphocyte ratio be used to determine gastric cancer treatment outcomes? a systematic review and meta-analysis","volume":"2016","author":"Sun","year":"2016","journal-title":"Dis. Markers"},{"key":"10.1016\/j.critrevonc.2024.104525_bib207","doi-asserted-by":"crossref","unstructured":"Sun, X.-D., Shi, X.-J., Chen, Y.-G., et al. 2016. Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis. 2016. Retrieved from <Go to ISI>:\/\/WOS:000370258300001.","DOI":"10.1155\/2016\/4743808"},{"key":"10.1016\/j.critrevonc.2024.104525_bib208","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.2147\/CMAR.S171035","article-title":"The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis","volume":"10","author":"Sun","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.critrevonc.2024.104525_bib209","doi-asserted-by":"crossref","unstructured":"Szor, D.J., Dias, A.R., Pereira, M.A., et al. 2018. Prognostic Role of Neutrophil\/Lymphocyte Ratio in Resected Gastric Cancer: A Systematic Review and Meta-analysis. 73, e360. Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L624082140&from=exporthttp:\/\/dx.doi.org\/10.6061\/clinics\/2018\/e360\u3009.","DOI":"10.6061\/clinics\/2018\/e360"},{"key":"10.1016\/j.critrevonc.2024.104525_bib210","doi-asserted-by":"crossref","unstructured":"Takenaka, Y., Kitamura, T., Oya, R., et al. 2017. Prognostic role of neutrophil\u2013lymphocyte ratio in nasopharyngeal carcinoma: A meta-analysis. 12(7). Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L617350896&from=exporthttp:\/\/dx.doi.org\/10.1371\/journal.pone.0181478\u3009.","DOI":"10.1371\/journal.pone.0181478"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104525_bib211","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/hed.25366","article-title":"Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: meta-analysis","volume":"40","author":"Takenaka","year":"2018","journal-title":"Head. neck"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib212","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/hed.24986","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: a meta-analysis","volume":"40","author":"Takenaka","year":"2018","journal-title":"Head. neck"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib213","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hed.26997","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: meta-analysis","volume":"44","author":"Takenaka","year":"2022","journal-title":"Head. neck"},{"key":"10.1016\/j.critrevonc.2024.104525_bib214","doi-asserted-by":"crossref","unstructured":"Tan, D.-W., Fu, Y., Su, Q., et al. 2016. Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis. 6. Retrieved from <Go to ISI>:\/\/WOS:000384755300001.","DOI":"10.1038\/srep33789"},{"issue":"24","key":"10.1016\/j.critrevonc.2024.104525_bib215","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003837","article-title":"Prognostic role of platelet-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis","volume":"95","author":"Tan","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2024.104525_bib216","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijsu.2018.05.030","article-title":"Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: a meta-analysis","volume":"55","author":"Tan","year":"2018","journal-title":"Int. J. Surg. (Lond., Engl. )"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104525_bib217","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/1759-7714.12815","article-title":"Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: a meta-analysis","volume":"9","author":"Tan","year":"2018","journal-title":"Thorac. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104525_bib218","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159447","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in colorectal liver metastasis: a systematic review and meta-analysis","volume":"11","author":"Tang","year":"2016","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.critrevonc.2024.104525_bib219","doi-asserted-by":"crossref","first-page":"36857","DOI":"10.18632\/oncotarget.16143","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153981","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in localized and advanced prostate cancer: a systematic review and meta-analysis","volume":"11","author":"Tang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2024.104525_bib221","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6688346","article-title":"Neutrophil-lymphocyte ratio as a prognostic parameter in NSCLC patients receiving EGFR-TKIs: a systematic review and meta-analysis","volume":"2021","author":"Tang","year":"2021","journal-title":"J. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib222","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10147-017-1171-5","article-title":"The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis","volume":"22","author":"Tang","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib223","doi-asserted-by":"crossref","unstructured":"Templeton, A.J., Ace, O., McNamara, M.G., et al. 2014. Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. 23(7), 1204-1212. Retrieved from <Go to ISI>:\/\/WOS:000345273700008.","DOI":"10.1158\/1055-9965.EPI-14-0146"},{"key":"10.1016\/j.critrevonc.2024.104525_bib224","unstructured":"Templeton, A.J., McNamara, M.G., Vera-Badillo, F.E., et al. 2013. Prognostic role of neutrophil to lymphocyte ratio (nlr) in solid tumors: A systematic review and meta-analysis. 49, S211. Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L71217534&from=exporthttp:\/\/dx.doi.org\/10.1016\/S0959-8049\u3009(13)70061-3."},{"key":"10.1016\/j.critrevonc.2024.104525_bib225","unstructured":"Teng, J.-J., Zhang, J., Zhang, T.-Y., et al. 2016. Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis. 9. Retrieved from <Go to ISI>:\/\/WOS:000367138300001."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104525_bib226","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/hed.25324","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis","volume":"40","author":"Tham","year":"2018","journal-title":"Head. neck"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104525_bib227","first-page":"1663","article-title":"The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis","volume":"275","author":"Tham","year":"2018","journal-title":"Eur. Arch. Oto-Rhino-Laryngol.: Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. (EUFOS): Affil. Ger. Soc. Oto-Rhino-Laryngol. - Head. Neck Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib228","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12917","article-title":"Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: a meta-analysis","volume":"48","author":"Tian","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104525_bib229","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4103\/0973-1482.144356","article-title":"Neutrophil-lymphocyte ratio and CEA level as prognostic and predictive factors in colorectal cancer: a systematic review and meta-analysis","volume":"12","author":"Tsai","year":"2016","journal-title":"J. Cancer Res. Ther."},{"issue":"24","key":"10.1016\/j.critrevonc.2024.104525_bib230","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/jnci\/djs437","article-title":"Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk","volume":"104","author":"Tsilidis","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104525_bib231","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00345-018-2235-5","article-title":"Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? a meta-analysis of 4385 patients","volume":"36","author":"Vartolomei","year":"2018","journal-title":"World J. Urol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib232","doi-asserted-by":"crossref","unstructured":"Vartolomei, M.D., Porav-Hodade, D., Ferro, M., et al. 2018. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non\u2013muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis. 36(9), 389-399. Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2000853294&from=exporthttp:\/\/dx.doi.org\/10.1016\/j.urolonc.2018.05.014\u3009.","DOI":"10.1016\/j.urolonc.2018.05.014"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib233","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/cts.12700","article-title":"Prognostic significance of preoperative systemic cellular inflammatory markers in gliomas: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2020","journal-title":"Clin. Transl. Sci."},{"issue":"38","key":"10.1016\/j.critrevonc.2024.104525_bib234","article-title":"Prognostic significance of platelet lymphocyte ratio in patients with melanoma: a meta-analysis","volume":"100","author":"Wang","year":"2021","journal-title":"Med. (Baltim. )"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268288","article-title":"Prognostic value of the platelet-to-lymphocyte ratio in lung cancer patients receiving immunotherapy: a systematic review and meta-analysis","volume":"17","author":"Wang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2024.104525_bib236","unstructured":"Wang,\u00a0H.,\u00a0Zhao,\u00a0F.,\u00a0Mu,\u00a0D.,\u00a0et al.,\u00a02017.\u00a0Platelet to lymphocyte ratio as a prognostic marker for hepatocellular carcinoma. 10(3).\u00a05811-5820. Retrieved\u00a0:\/\/WOS\u00a0000400552900187."},{"key":"10.1016\/j.critrevonc.2024.104525_bib237","article-title":"The ratio of platelets to lymphocytes predicts the prognosis of metastatic colorectal cancer: a review and meta-analysis","volume":"2021","author":"Wang","year":"2021","journal-title":"Gastroenterol. Res Pr."},{"issue":"41","key":"10.1016\/j.critrevonc.2024.104525_bib238","doi-asserted-by":"crossref","first-page":"70874","DOI":"10.18632\/oncotarget.20147","article-title":"Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"40","key":"10.1016\/j.critrevonc.2024.104525_bib239","article-title":"Prognostic role of platelet to lymphocyte ratio in prostate cancer: a meta-analysis","volume":"97","author":"Wang","year":"2018","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.critrevonc.2024.104525_bib240","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fonc.2019.00757","article-title":"Prognostic role of platelet-to-lymphocyte ratio in patients with bladder cancer: a meta-analysis","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol."},{"issue":"48","key":"10.1016\/j.critrevonc.2024.104525_bib241","doi-asserted-by":"crossref","first-page":"84506","DOI":"10.18632\/oncotarget.21108","article-title":"The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104525_bib242","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1159\/000501726","article-title":"Prognostic value of pretreatment lymphocyte-to-monocyte ratio in non-small cell lung cancer: a meta-analysis","volume":"42","author":"Wang","year":"2019","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.critrevonc.2024.104525_bib243","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijsu.2018.05.022","article-title":"The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: a systematic review and meta-analysis","volume":"55","author":"Wang","year":"2018","journal-title":"Int J. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib244","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/jop.12688","article-title":"Meta-analysis of the prognostic value of the neutrophil-to-lymphocyte ratio in oral squamous cell carcinoma","volume":"47","author":"Wang","year":"2018","journal-title":"J. Oral. Pathol. Med"},{"key":"10.1016\/j.critrevonc.2024.104525_bib245","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.2147\/CMAR.S159105","article-title":"Neutrophil-lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis.","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib246","doi-asserted-by":"crossref","first-page":"214","DOI":"10.21037\/tlcr.2019.06.10","article-title":"Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis","volume":"8","author":"Wang","year":"2019","journal-title":"Transl. lung Cancer Res."},{"key":"10.1016\/j.critrevonc.2024.104525_bib247","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.2147\/OTT.S108419","article-title":"The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis","volume":"9","author":"Wei","year":"2016","journal-title":"Onco Targets Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib248","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092079","article-title":"Prognostic role of NLR in urinary cancers: a meta-analysis","volume":"9","author":"Wei","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib249","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.21037\/tcr-20-1037","article-title":"The prognostic roles of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in gastrointestinal stromal tumours: a meta-analysis","volume":"9","author":"Wei","year":"2020","journal-title":"Transl. Cancer Res"},{"key":"10.1016\/j.critrevonc.2024.104525_bib250","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jad.2024.06.098","article-title":"Sex-specific association of peripheral blood cell indices and inflammatory markers with depressive symptoms in early adolescence","volume":"362","author":"Wen","year":"2024","journal-title":"J. Affect Disord."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib251","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13643-021-01585-w","article-title":"Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis","volume":"10","author":"Winther-Larsen","year":"2021","journal-title":"Syst. Rev."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104525_bib252","doi-asserted-by":"crossref","first-page":"13400","DOI":"10.18632\/oncotarget.14541","article-title":"Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib253","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250091","article-title":"Prognostic value of the postoperative neutrophil-lymphocyte ratio in solid tumors: a meta-analysis","volume":"16","author":"Wu","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2024.104525_bib254","doi-asserted-by":"crossref","unstructured":"Wu, Q., Hu, T., Zheng, E., et al. 2017. Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer. 96(22). Retrieved from \u3008https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L616787651&from=exporthttp:\/\/dx.doi.org\/10.1097\/MD.0000000000007051\u3009.","DOI":"10.1097\/MD.0000000000007051"},{"issue":"53","key":"10.1016\/j.critrevonc.2024.104525_bib255","doi-asserted-by":"crossref","first-page":"91694","DOI":"10.18632\/oncotarget.21162","article-title":"Systematic review and meta-analysis of the prognostic value of preoperative platelet-to-lymphocyte ratio in patients with urothelial carcinoma","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104525_bib256","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/2211-5463.12066","article-title":"Prognostic significance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis","volume":"6","author":"Xia","year":"2016","journal-title":"Febs Open Bio"},{"key":"10.1016\/j.critrevonc.2024.104525_bib257","article-title":"Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis","volume":"14","author":"Xiao","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2024.104525_bib258","article-title":"Prognostic Value of Peripheral Whole Blood Cell Counts Derived Indexes in Gallbladder Carcinoma: A Systematic Review and Meta-Analysis","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105957","article-title":"Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"77","author":"Xu","year":"2019","journal-title":"Int Immunopharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib260","doi-asserted-by":"crossref","first-page":"552","DOI":"10.21037\/tcr.2018.05.13","article-title":"Prognostic significance of the platelet-to-lymphocyte ratio in ovarian cancer: a meta-analysis","volume":"7","author":"Xu","year":"2018","journal-title":"Transl. Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104525_bib261","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2217\/bmm-2017-0307","article-title":"The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis","volume":"12","author":"Xu","year":"2018","journal-title":"Biomark. Med."},{"key":"10.1016\/j.critrevonc.2024.104525_bib262","doi-asserted-by":"crossref","unstructured":"Xu, Z.-S., Zhang, F.-P., Zhang, Y., et al. 2017. Prognostic role of the pre-treatment platelet-lymphocyte ratio in pancreatic cancer: a meta-analysis. Oncotarget, 8(58), 99003-99012. Retrieved from <Go to ISI>:\/\/WOS:000419392300102.","DOI":"10.18632\/oncotarget.20871"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib263","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163719","article-title":"The prognostic role of the platelet-lymphocytes ratio in gastric cancer: a meta-analysis","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib264","article-title":"Prognostic role of high neutrophil-to-lymphocyte ratio in breast cancer patients receiving neoadjuvant chemotherapy: meta-analysis","volume":"98","author":"Xue","year":"2019","journal-title":"Med. (Baltim. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib265","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10147-021-02061-0","article-title":"Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis","volume":"27","author":"Yanagisawa","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib266","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.580101","article-title":"Systemic inflammatory indicators as prognosticators in glioblastoma patients: a comprehensive meta-analysis","volume":"11","author":"Yang","year":"2020","journal-title":"Front Neurol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104525_bib267","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00405-020-06337-5","article-title":"Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in patients with laryngeal cancer: a systematic review and meta-analysis","volume":"278","author":"Yang","year":"2021","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"47","key":"10.1016\/j.critrevonc.2024.104525_bib268","doi-asserted-by":"crossref","first-page":"76769","DOI":"10.18632\/oncotarget.12526","article-title":"Prognostic significance of neutrophil-lymphocyteratio\/platelet-lymphocyteratioin lung cancers: a meta-analysis","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib269","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3748\/wjg.v21.i9.2807","article-title":"Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis","volume":"21","author":"Yang","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib270","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/ijgc-2018-000090","article-title":"Establishing the prognostic value of platelet-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis","volume":"29","author":"Yang","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib271","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/hed.25583","article-title":"High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: systematic review and meta-analysis","volume":"41","author":"Yang","year":"2019","journal-title":"Head. Neck"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104525_bib272","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.7150\/jca.26770","article-title":"Prognostic significance of hematological markers for patients with nasopharyngeal carcinoma: a meta-analysis","volume":"10","author":"Yang","year":"2019","journal-title":"J. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib273","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049123","article-title":"Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis","volume":"11","author":"Yang","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.critrevonc.2024.104525_bib274","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2147\/OTT.S77099","article-title":"Prognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysis","volume":"8","author":"Yang","year":"2015","journal-title":"Onco Targets Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104525_bib275","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181550","article-title":"Prognostic and clinicopathological significance of neutrophil-to-lymphocyte ratio in patients with oral cancer","volume":"38","author":"Yang","year":"2018","journal-title":"Biosci. Rep."},{"issue":"28","key":"10.1016\/j.critrevonc.2024.104525_bib276","doi-asserted-by":"crossref","first-page":"46414","DOI":"10.18632\/oncotarget.16793","article-title":"Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"29","key":"10.1016\/j.critrevonc.2024.104525_bib277","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007577","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma A meta-analysis","volume":"96","author":"Yin","year":"2017","journal-title":"Medicine"},{"issue":"45","key":"10.1016\/j.critrevonc.2024.104525_bib278","article-title":"Prognostic significance of neutrophil-lymphocyte ratio (NLR) in patients with ovarian cancer: A systematic review and meta-analysis","volume":"98","author":"Yin","year":"2019","journal-title":"Med. (Baltim. )"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib279","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in prostate cancer: a systematic review and meta-analysis","volume":"95","author":"Yin","year":"2016","journal-title":"Med. (Baltim. )"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104525_bib280","doi-asserted-by":"crossref","first-page":"524","DOI":"10.6061\/clinics\/2015(07)10","article-title":"Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: a meta-analysis","volume":"70","author":"Yin","year":"2015","journal-title":"Clinics"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104525_bib281","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1245\/s10434-015-4869-5","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis","volume":"23","author":"Yodying","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib282","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.breast.2019.09.013","article-title":"Associations between absolute neutrophil count and lymphocyte-predominant breast cancer","volume":"50","author":"Yoon","year":"2020","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2024.104525_bib283","unstructured":"Yu, B., Li, Z., Zheng, Q., et al. 2017. Prognostic value of neutrophil to lymphocyte ratio in patients with nasopharyngeal carcinoma: A meta-analysis. Biomedical Research-India, 28(3), 1378-1382. Retrieved from <Go to ISI>:\/\/WOS:000396822900073."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib284","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3892\/mco.2017.1342","article-title":"Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: a meta-analysis of 7,219 patients","volume":"7","author":"Yu","year":"2017","journal-title":"Mol. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib285","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12885-018-4230-z","article-title":"Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Cancer"},{"issue":"41","key":"10.1016\/j.critrevonc.2024.104525_bib286","article-title":"Prognostic value of neutrophil to lymphocyte ratio and clinicopathological characteristics for multiple myeloma: a meta-analysis","volume":"97","author":"Zeng","year":"2018","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.critrevonc.2024.104525_bib287","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2018.05.055","article-title":"Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: a meta-analysis","volume":"484","author":"Zhan","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.critrevonc.2024.104525_bib288","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3389\/fonc.2020.01116","article-title":"Prognostic value of the platelet-to-lymphocyte ratio in patients with melanoma: a meta-analysis","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib289","article-title":"Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2217\/fon-2019-0520","article-title":"Prognostic significance of platelet-to-lymphocyte ratio in patients with nasopharyngeal carcinoma: a meta-analysis","volume":"16","author":"Zhang","year":"2020","journal-title":"Future Oncol."},{"issue":"40","key":"10.1016\/j.critrevonc.2024.104525_bib291","doi-asserted-by":"crossref","first-page":"68837","DOI":"10.18632\/oncotarget.18575","article-title":"The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"30","key":"10.1016\/j.critrevonc.2024.104525_bib292","article-title":"Meta-analysis of multiple hematological biomarkers as prognostic predictors of survival in bladder cancer","volume":"99","author":"Zhang","year":"2020","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.critrevonc.2024.104525_bib293","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9503025","article-title":"High platelet-to-lymphocyte ratio predicts poor prognosis and clinicopathological characteristics in patients with breast cancer: a meta-analysis","volume":"2017","author":"Zhang","year":"2017","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.critrevonc.2024.104525_bib294","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106677","article-title":"Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis","volume":"85","author":"Zhang","year":"2020","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib295","article-title":"Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis","volume":"56","author":"Zhang","year":"2024","journal-title":"Ann. Med"},{"key":"10.1016\/j.critrevonc.2024.104525_bib296","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijsu.2015.07.681","article-title":"The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysis","volume":"21","author":"Zhang","year":"2015","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.critrevonc.2024.104525_bib297","article-title":"Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR\/MLR) clinically significant prognostic biomarkers in multiple myeloma? a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol."},{"issue":"49","key":"10.1016\/j.critrevonc.2024.104525_bib298","article-title":"Prognostic role of neutrophil-lymphocyte ratio in esophageal cancer: a systematic review and meta-analysis","volume":"97","author":"Zhang","year":"2018","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.critrevonc.2024.104525_bib299","doi-asserted-by":"crossref","DOI":"10.1177\/1724600818766889","article-title":"Prognostic value of platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis","author":"Zhang","year":"2018","journal-title":"Int J. Biol. Markers"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104525_bib300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111906","article-title":"Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib301","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12957-020-01952-2","article-title":"Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis","volume":"18","author":"Zhang","year":"2020","journal-title":"World J. Surg. Oncol."},{"issue":"32","key":"10.1016\/j.critrevonc.2024.104525_bib302","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029536","article-title":"Prognostic value of neutrophil-lymphocyte ratio and lactate dehydrogenase in melanoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2024.104525_bib303","unstructured":"Zhang, Y., Wang, W., & Lyu, L. 2020. Prognostic role of neutrophil\/lymphocyte ratio (NLR) in patients with non-small-cell lung cancer treated with PD-1\/PD-L1 inhibitors: a meta-analysis. International Journal of Clinical and Experimental Medicine, 13(12), 9194-9206. Retrieved from <Go to ISI>:\/\/WOS:000605020700012."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib304","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/jop.12832","article-title":"Prognostic role of platelet-to-lymphocyte ratio in oral cancer: a meta-analysis","volume":"50","author":"Zhang","year":"2021","journal-title":"J. Oral. Pathol. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib305","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.21037\/jgo-22-683","article-title":"The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis","volume":"13","author":"Zhao","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib306","unstructured":"Zhao,\u00a0Q.-T.,\u00a0Yang,\u00a0Y.,\u00a0Xu,\u00a0S.,\u00a0et al.,\u00a02015.\u00a0Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients.\u00a08. Retrieved\u00a0:\/\/WOS\u00a0000362293100002."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib307","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ijc.30060","article-title":"Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients","volume":"139","author":"Zhao","year":"2016","journal-title":"Int J. Cancer"},{"issue":"67","key":"10.1016\/j.critrevonc.2024.104525_bib308","doi-asserted-by":"crossref","first-page":"112085","DOI":"10.18632\/oncotarget.22557","article-title":"Prognostic role of platelet to lymphocyte ratio in esophageal cancer: a meta-analysis","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104525_bib309","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bjorl.2020.09.015","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio to laryngeal squamous cell carcinoma: a meta-analysis","volume":"88","author":"Zhao","year":"2022","journal-title":"Braz. J. Otorhinolaryngol."},{"issue":"14","key":"10.1016\/j.critrevonc.2024.104525_bib310","doi-asserted-by":"crossref","first-page":"22854","DOI":"10.18632\/oncotarget.15281","article-title":"Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104525_bib311","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00404-018-4678-8","article-title":"Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies","volume":"297","author":"Zhao","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib312","first-page":"78","article-title":"Neutrophil-lymphocyte ratio predicts the prognosis of patients with colorectal cancer: a meta-analysis","volume":"9","author":"Zheng","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib313","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1159\/000485396","article-title":"Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various treatments: a meta-analysis and systematic review","volume":"44","author":"Zheng","year":"2017","journal-title":"Cell Physiol. Biochem"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104525_bib314","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.21037\/tcr-20-3125","article-title":"Neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers to predict relapse and survival in posthepatectomy HBV-related hepatocellular carcinoma: a meta-analysis and preliminary immune perspective","volume":"10","author":"Zheng","year":"2021","journal-title":"Transl. Cancer Res"},{"key":"10.1016\/j.critrevonc.2024.104525_bib315","article-title":"Platelet-lymphocyte ratio is a prognostic marker in small cell lung cancer-a systemic review and meta-analysis","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib316","article-title":"Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: a systematic review and meta-analysis","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2024.104525_bib317","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cca.2017.09.006","article-title":"Platelet to lymphocyte ratio in biliary tract cancer: review and meta-analysis","volume":"474","author":"Zhou","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104525_bib318","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047957","article-title":"Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis","volume":"11","author":"Zhou","year":"2021","journal-title":"BMJ Open"},{"issue":"40","key":"10.1016\/j.critrevonc.2024.104525_bib319","doi-asserted-by":"crossref","first-page":"68938","DOI":"10.18632\/oncotarget.20196","article-title":"Prognostic significance of neutrophil to lymphocyte ratio in ovarian cancer: evidence from 4,910 patients","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2024.104525_bib320","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2147\/OTT.S154162","article-title":"Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies","volume":"11","author":"Zhou","year":"2018","journal-title":"Onco Targets Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib321","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2024.104525_bib322","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2018.01.024","article-title":"Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis containing 8252 patients","volume":"479","author":"Zhou","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib323","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.18632\/oncotarget.13714","article-title":"Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104525_bib324","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79071-x","article-title":"Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysis","volume":"10","author":"Zou","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824002683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824002683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T04:06:28Z","timestamp":1732939588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842824002683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":324,"alternative-id":["S1040842824002683"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104525","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between peripheral whole blood cell counts derived indexes and cancer prognosis: An umbrella review of meta-analyses of cohort studies","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104525"}}